<DOC>
	<DOCNO>NCT01020019</DOCNO>
	<brief_summary>The purpose study see Lofexidine combination Marinol superior placebo achieve abstinence , reduce cannabis use reduce withdrawal cannabis-dependent patient seek treatment marijuana use .</brief_summary>
	<brief_title>Combined Pharmacotherapy Cannabis Dependency</brief_title>
	<detailed_description>Cannabis use disorder remain common illicit drug use disorder option treatment remain limited . Compared abusable substance , little investigation pharmacotherapies cannabis dependence effective pharmacotherapy cannabis dependence yet develop . The development effective cannabis dependence pharmacotherapy important unmet public health need . Agonist pharmacotherapy strategy effective substance use disorder ( e.g. , opioid nicotine use disorder ) endocannabinoid system represent promise target agonist pharmacotherapy dronabinol . Lofexidine , noradrenergic system suppressant , effective treat opioid withdrawal show promise cannabis use disorder pharmacotherapy . Haney et al . ( 2008 ) find combination lofexidine dronabinol ( Lofex-Dro ) superior placebo , lofexidine alone , dronabinol alone improve sleep cannabis withdrawal symptom . Further , reduction crave relapse great combine pharmacotherapy relative either medication alone placebo . The propose protocol 2 group , double blind , placebo-controlled outpatient study safety efficacy combination dronabinol lofexidine treatment cannabis dependence . We plan enroll 180 subject 12-week trial . The primary hypothesis dronabinol act agonist treatment lofexidine suppress craving- cue-induced related stress combination act complementary manner induce prolonged abstinence marijuana .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<criteria>1 . Men woman age 1860 meet DSMIV criterion current marijuana dependence 2 . Individuals must report use marijuana least 5 day week positive urine test THC day study entry . 3 . Individual must describe marijuana primary drug abuse . 4 . Individuals must capable give informed consent capable comply study procedure . 1 . Meets DSMIVTR criterion schizophrenia , schizoaffective illness , psychotic disorder transient psychosis due drug abuse , major depression , bipolar illness psychiatric disorder ( substance abuse ) require psychiatric intervention . 2 . Individuals medically unstable base laboratory test , electrocardiogram , medical history , physical examination would make participation hazardous 3 . Individuals liver enzyme function test great three time normal 4 . Individuals history seizure disorder 5 . Individuals current suicidal risk . 6 . Individuals cognitively impair 7 . Bradycardia ( &lt; 50 beats/minute ) , hypotension ( sit stand BP &lt; 90/50 ) , symptom attributable low BP ( i.e . lightheadedness dizziness stand ) . 8 . Nursing mother pregnant woman . Women child bear age include study provide pregnant , base result blood pregnancy test drawn time screen . They must also agree use method contraception proven efficacy agree become pregnant study . To confirm , urine pregnancy test repeat monthly . Women provide full explanation potential danger pregnancy study medication . If woman become pregnant , study medication discontinue . 9 . Individuals physiologically dependent drug ( exclude nicotine ) would require medical intervention 10 . Individuals know sensitivity dronabinol lofexidine 11 . Individuals coronary vascular disease indicate history suspect abnormal ECG history cardiac symptoms 12 . Individuals currently treat alpha2 agonist antihypertensive medication 13 . Individuals currently prescribe psychotropic medication ( include sleep medication ) . However , medication depression allow stable least 1 month . 14 . Individuals job even mild intoxication would hazardous ( e.g. , firefighter , bus driver ) 15 . Individuals courtmandated treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cannabis Dependence</keyword>
	<keyword>Marijuana Dependence</keyword>
	<keyword>Marinol</keyword>
	<keyword>Lofexidine</keyword>
</DOC>